Does intravenous injection of ramosetron affect the hemodynamic changes during anesthetic induction by total intravenous anesthesia with propofol and remifentanil? - a randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006801

Enrollment

186

Registered

2021-12-02

Start date

2022-03-24

Completion date

Unknown

Last updated

2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is a prospective, double-blind, and randomized controlled study. Using a double-blinded randomization method, a total of 186 subjects are randomly assigned to a total of 3 groups (1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Total intravenous anesthesia performed using propofol and remifentanil Adults aged 20 to 65 years old I, II, III of the American Society of Anesthesiologists (ASA) Physical Status classification Patients who voluntarily agreed to participate in this clinical study.

Exclusion criteria

Exclusion criteria: Patients who are allergic to this drug or other ingredients of this drug Emergency Surgery Patients receiving selective serotonin resorption inhibitor (SSRI) Patients receiving serotonin noradrenaline reabsorption inhibitor (SNRI), etc.

Design outcomes

Primary

Measure	Time frame
Difference between blood pressure (systolic,diastolic, mean) and heart rate	—

Secondary

Measure	Time frame
Blood pressure (systolic,diastolic, mean) and heart rate;Difference between blood pressure (systolic,diastolic, mean) and heart rate ;Presence of hypertension, hypotension, bradycardia, and tachycardia during anesthesia	—

Countries

Korea, Republic of

Contacts

Public ContactSang Hun Kim

Chosun University Hospital

ksh3223@chosun.ac.kr+82-62-220-3578

Outcome results